home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

The Long And The Short Of Fatty Liver

  October, 3 2007 9:22
your information resource in human molecular genetics
Too much fat in the liver predisposes to diabetes, but a study in the October 2007 issue of Nature Medicine reports that not all types of fat are equally harmful. Changing the fat composition in the liver may therefore help obese patients who are insulin resistant and cannot lose weight.

Excessive fat intake leads to obesity and overwhelms the storage capacity of fat cells, with surplus fat being stored in the liver. Development of fatty liver can result in insulin resistance and increased glucose levels -- two hallmarks of diabetes.

Hitoshi Shimano and his colleagues created a strain of mice lacking Elovl6, an enzyme that increases the length of the carbon chains of fatty acids, thereby changing the fat composition in the liver of these mutant mice, with shorter fatty acids predominating over those with longer chains. On a high-fat diet, these mice became obese and developed fatty liver, just like wild-type mice, but their insulin sensitivity and their sugar levels were not affected.

The absolute levels of fat in the liver do not therefore seem to be detrimental to maintaining normal glucose levels. Instead, the types of fat that are present seem to be a more important factor, with shorter fat molecules being healthier than longer ones. If this is also true in humans, it may be possible to help obese patients who are insulin resistant and cannot lose weight by targeting Elovl6.

Author contact:

Hitoshi Shimano (University of Tsukuba, Ibaraki, Japan)

E-mail: shimano-tky@umin.ac.jp

Abstract available online.

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.